Schipmann, S <br/><br/>
Osteopathology associated with bone resorption inhibitors - which role does Actinomyces play? A presentation of 51 cases with systematic review of the literature.  [electronic resource] 

 -  Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology  Sep 2013 
 - 587-93 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Review; Systematic Review 
<br/><br/><label>ISSN: </label>1600-0714 
<br/><br/><label>Standard No.: </label>10.1111/jop.12038  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Actinomyces--isolation & purification<br/>Actinomycosis--diagnosis<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Alendronate--adverse effects<br/>Antibodies, Monoclonal, Humanized--adverse effects<br/>Biopsy<br/>Bisphosphonate-Associated Osteonecrosis of the Jaw--etiology<br/>Bone Density Conservation Agents--adverse effects<br/>Denosumab<br/>Diphosphonates--adverse effects<br/>Female<br/>Humans<br/>Imidazoles--adverse effects<br/>Male<br/>Middle Aged<br/>RANK Ligand--antagonists & inhibitors<br/>Retrospective Studies<br/>Tooth Extraction--adverse effects<br/>Zoledronic Acid